What's breaking now, across thousands of outlets.
The stock market is celebrating the study success of Moderna and Merck. A personalized cancer vaccine is getting closer and could become a game changer for cancer medicine.
We haven't written up this one. Handelsblatt has the full story — the link below goes straight to it.
PrEP is an HIV prevention intervention for people who do not have HIV but may be at risk of acquiring the virus. It involves the use of medicines to reduce the risk of HIV infection.
A scientific and civilizational horror story.
Eli Lilly’s triple agonist retatrutide appears to be the most effective obesity drug to have reached late-stage trials, with weight loss of up to 25% in Phase 3. This has led growing ...
The clearance of Genglycos for a rare glycogen storage disease gives Ultragenyx a sellable voucher and momentum ahead of an eagerly anticipated study readout.
Health department has called upon households, institutions and the community to work together to eliminate mosquito-breeding sources
